Cargando…

From Science to Success? Targeting Tyrosine Kinase 2 in Spondyloarthritis and Related Chronic Inflammatory Diseases

Spondyloarthritis (SpA) is a family of inflammatory arthritic diseases, which includes the prototypes of psoriatic arthritis and ankylosing spondylitis. SpA is commonly associated with systemic inflammatory diseases, such as psoriasis and inflammatory bowel disease. Immunological studies, murine mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromadová, Dominika, Elewaut, Dirk, Inman, Robert D., Strobl, Birgit, Gracey, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287328/ https://www.ncbi.nlm.nih.gov/pubmed/34290741 http://dx.doi.org/10.3389/fgene.2021.685280

Ejemplares similares

TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis
por: Gracey, Eric, et al.
Publicado: (2020)

Inflammatory Foot Involvement in Spondyloarthritis: From Tarsitis to Ankylosing Tarsitis
por: Romero-López, José Pablo, et al.
Publicado: (2021)

The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019)

Progress in spondylarthritis. Immunopathogenesis of spondyloarthritis: which cells drive disease?
por: Melis, Lode, et al.
Publicado: (2009)

The First Reported Case of Neurotrophic Tyrosine Receptor Kinase Fusion-Positive Thymoma Treated Successfully With Entrectinib
por: Salame, Hassan, et al.
Publicado: (2021)

Receptor tyrosine kinases and schistosome reproduction: new targets for chemotherapy
por: Morel, Marion, et al.
Publicado: (2014)

The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?
por: Omarjee, Loukman, et al.
Publicado: (2017)

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
por: Paramarta, Jacqueline E., et al.
Publicado: (2016)

Spondyloarthritis: How far are we from precision medicine?
por: So, Jacqueline, et al.
Publicado: (2022)

Editorial: Genetic Studies on Spondyloarthritis: From Disease Predictors to Therapeutic Targets
por: Vecellio, Matteo, et al.
Publicado: (2022)

Shedding Light on the Role of ERAP1 in Axial Spondyloarthritis
por: Saad, Mohamed A, et al.
Publicado: (2023)

Crossing the boundaries: IL-23 and its role in linking inflammation of the skin, gut and joints
por: Łukasik, Zuzanna, et al.
Publicado: (2021)

In vitro triple coculture with gut microbiota from spondyloarthritis patients is characterized by inter-individual differences in inflammatory responses
por: Beterams, Annelore, et al.
Publicado: (2022)

The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review
por: Ortolan, Augusta, et al.
Publicado: (2021)

What Have We Learned From Family-Based Studies About Spondyloarthritis?
por: Costantino, Félicie, et al.
Publicado: (2021)

Axial Spondyloarthritis: Current Advances, Future Challenges
por: Inman, Robert D
Publicado: (2021)

Significant Gene Biomarker Tyrosine Kinase Non-receptor 2 Mediated Cell Proliferation and Invasion in Colon Cancer
por: Ling, Sunkai, et al.
Publicado: (2021)

MRI of the axial skeleton in spondyloarthritis: the many faces of new bone formation
por: Laloo, Frederiek, et al.
Publicado: (2019)

Philadelphia Chromosome-Positive De Novo Acute Myeloid Leukemia Treated With Chemotherapy and Second-Generation Tyrosine Kinase Inhibitor
por: Muñoz, Juan D, et al.
Publicado: (2019)

Referral Patterns, Diagnosis, and Disease Management of Patients With Axial Spondyloarthritis: Results of an International Survey
por: van der Heijde, Désirée, et al.
Publicado: (2014)

Targeting inflammatory pathways in axial spondyloarthritis
por: Furst, Daniel E., et al.
Publicado: (2019)

Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations
por: Chimenti, Maria Sole, et al.
Publicado: (2021)

Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
por: Neys, Stefan F. H., et al.
Publicado: (2021)

Interdigital Hyperplasia in Holstein Cattle Is Associated With a Missense Mutation in the Signal Peptide Region of the Tyrosine-Protein Kinase Transmembrane Receptor Gene
por: Zhang, Xuying, et al.
Publicado: (2019)

Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation
por: Daniels, Hannah G., et al.
Publicado: (2022)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
por: Zhou, Yaqi, et al.
Publicado: (2023)

Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
por: Wang, Runsheng, et al.
Publicado: (2021)

Associations of mRNA:microRNA for the Shared Downstream Molecules of EGFR and Alternative Tyrosine Kinase Receptors in Non-small Cell Lung Cancer
por: Wang, Fengfeng, et al.
Publicado: (2016)

Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint
por: Karow, Fabian, et al.
Publicado: (2021)

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia
por: Stuckey, Ruth, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success
por: Inzoli, Elena, et al.
Publicado: (2022)

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis
por: Carron, Philippe, et al.
Publicado: (2016)

The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights
por: Toussirot, Eric
Publicado: (2022)

Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis
por: Tu, Liudan, et al.
Publicado: (2021)

Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy
por: Soverini, Simona, et al.
Publicado: (2018)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
por: Szilveszter, Kata P., et al.
Publicado: (2019)

Transcriptome Analysis of the Breast Muscle of Xichuan Black-Bone Chickens Under Tyrosine Supplementation Revealed the Mechanism of Tyrosine-Induced Melanin Deposition
por: Li, Donghua, et al.
Publicado: (2019)

Successful treatment of chronic myeloid leukemia with tyrosine kinase inhibitors goes beyond access to drugs
por: Conchon, Monika
Publicado: (2013)

Biology and therapeutic potential of mesenchymal stem cell extracellular vesicles in axial spondyloarthritis
por: Tavasolian, Fataneh, et al.
Publicado: (2023)

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
por: Armaka, Maria, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_u0tnkkgh55mqva99p44p6727mt